About the Journal
Aims and scope
Rheumatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality preclinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of rheumatologic therapies. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.
Areas of focus include, but are not limited to, rheumatoid arthritis, gout, gouty arthritis, psoriatic arthritis, osteoarthritis, juvenile idiopathic/rheumatoid arthritis, systemic lupus erythematosus, axial spondyloarthritis, Pompe’s disease, inflammatory joint conditions, musculoskeletal conditions, systemic sclerosis, and fibromyalgia.
The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, and short communications. The journal appeals to a global audience and receives submissions from all over the world.
Moving forward from traditional publishing, Rheumatology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include slide sets, videos, animations, and/or interactive learning resources. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.
Rheumatology and Therapy publishes supplements and special issues (in English or a local language). Material appropriate for supplements/special issues include: sponsored meeting proceedings, roundtable discussions, workshop reports, case series, and collections of articles on the same topic. All articles are subject to peer review, and must adhere to the ICMJE and GPP policies on acknowledgments/disclosures. Proposals for supplements are welcomed, and should be addressed to email@example.com.
Rheumatology and Therapy's rapid publication, personalized service, and open access is funded by article processing charges. Current fees are: £250/ €340/ $380 per printed page. Please note, all manuscripts are thoroughly peer reviewed and accepted/rejected based purely on the merit of the content.
For more information about the journal, please contact firstname.lastname@example.org.
Published: Online. Articles are published online as soon as the author approves their proofs as “online first.” Once your article is online, it has full pagination and a DOI number, making it instantly citable. Paginated issues are collated twice a year (June and December).
eISSN:2198-6584↑ Back to top